<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.ajmc.com/view/access-coverage-and-final-reflections-on-managing-alzheimer-s-disease-agitation</loc><lastmod>2026-07-16T21:25:00.000Z</lastmod><news:news><news:publication_date>2026-08-10T21:25:00Z</news:publication_date>
        <news:title><![CDATA[Access, Coverage, and Final Reflections on Managing Alzheimer's Disease Agitation]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/choosing-between-approved-therapies-differentiation-sequencing-and-black-box-warning-navigation-in-alzheimer-s-disease-agitation</loc><lastmod>2026-07-16T21:24:00.000Z</lastmod><news:news><news:publication_date>2026-08-10T21:24:00Z</news:publication_date>
        <news:title><![CDATA[Choosing Between Approved Therapies: Differentiation, Sequencing, and Black Box Warning Navigation in Alzheimer's Disease Agitation]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/comparing-the-two-approved-therapies-dextromethorphan-bupropion-and-brexpiprazole-in-alzheimer-s-disease-agitation</loc><lastmod>2026-07-16T21:22:00.000Z</lastmod><news:news><news:publication_date>2026-08-10T21:22:00Z</news:publication_date>
        <news:title><![CDATA[Comparing the Two Approved Therapies: Dextromethorphan-Bupropion and Brexpiprazole in Alzheimer's Disease Agitation]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/brexpiprazole-and-dextromethorphan-bupropion-mechanisms-of-action-and-key-clinical-trial-data-for-approved-alzheimer-s-disease-agitation-therapies</loc><lastmod>2026-07-16T21:20:00.000Z</lastmod><news:news><news:publication_date>2026-08-10T21:20:00Z</news:publication_date>
        <news:title><![CDATA[Brexpiprazole and Dextromethorphan-Bupropion: Mechanisms of Action and Key Clinical Trial Data for Approved Alzheimer's Disease Agitation Therapies]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/traditional-pharmacologic-therapies-for-alzheimer-s-disease-agitation-mechanisms-evidence-and-adverse-events</loc><lastmod>2026-07-16T21:18:00.000Z</lastmod><news:news><news:publication_date>2026-08-10T21:18:00Z</news:publication_date>
        <news:title><![CDATA[Traditional Pharmacologic Therapies for Alzheimer's Disease Agitation: Mechanisms, Evidence, and Adverse Events]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/non-pharmacologic-approaches-to-alzheimer-s-disease-agitation-interventions-best-practices-and-case-examples</loc><lastmod>2026-07-16T21:16:00.000Z</lastmod><news:news><news:publication_date>2026-08-10T21:16:00Z</news:publication_date>
        <news:title><![CDATA[Non-Pharmacologic Approaches to Alzheimer's Disease Agitation: Interventions, Best Practices, and Case Examples]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/closing-the-recognition-gap-underdiagnosis-patient-education-and-treatment-goals-in-alzheimer-s-disease-agitation</loc><lastmod>2026-07-16T21:10:00.000Z</lastmod><news:news><news:publication_date>2026-08-10T21:10:00Z</news:publication_date>
        <news:title><![CDATA[Closing the Recognition Gap: Underdiagnosis, Patient Education, and Treatment Goals in Alzheimer's Disease Agitation]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/the-burden-of-alzheimer-s-disease-agitation-impact-on-patients-caregivers-and-quality-of-life</loc><lastmod>2026-07-16T21:05:00.000Z</lastmod><news:news><news:publication_date>2026-08-10T21:05:36.334Z</news:publication_date>
        <news:title><![CDATA[The Burden of Alzheimer's Disease Agitation: Impact on Patients, Caregivers, and Quality of Life]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/senate-unveils-sweeping-bill-to-reform-340b-drug-program</loc><lastmod>2026-08-10T20:52:05.831Z</lastmod><news:news><news:publication_date>2026-08-10T20:52:05.831Z</news:publication_date>
        <news:title><![CDATA[Senate Unveils Sweeping Bill to Reform 340B Drug Program]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/readable-consent-forms-could-boost-trial-enrollment-oyepeju-abioye-akintola-md-msc</loc><lastmod>2026-08-10T20:49:24.995Z</lastmod><news:news><news:publication_date>2026-08-10T20:49:24.995Z</news:publication_date>
        <news:title><![CDATA[Readable Consent Forms Could Boost Trial Enrollment: Oyepeju Abioye-Akintola, MD, MSc]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/upmc-health-plan-earns-highest-member-satisfaction-scores-in-pennsylvania-from-jd-power</loc><lastmod>2026-08-10T19:23:35.749Z</lastmod><news:news><news:publication_date>2026-08-10T19:23:35.749Z</news:publication_date>
        <news:title><![CDATA[UPMC Health Plan Earns Highest Member Satisfaction Scores in Pennsylvania From JD Power]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/occupational-triggers-chronic-hand-eczema-spanish-cohort</loc><lastmod>2026-08-10T18:03:16.987Z</lastmod><news:news><news:publication_date>2026-08-10T18:03:16.987Z</news:publication_date>
        <news:title><![CDATA[Occupational Triggers Fuel Half of CHE Cases, Spanish Study Finds]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/jak-inhibitor-hesitancy-and-step-therapy-in-pediatric-alopecia-areata-brittany-craiglow-md</loc><lastmod>2026-08-10T18:00:00Z</lastmod><news:news><news:publication_date>2026-08-10T18:00:00Z</news:publication_date>
        <news:title><![CDATA[JAK Inhibitor Hesitancy and Step Therapy in Pediatric Alopecia Areata: A Q&A With Brittany Craiglow, MD]]></news:title>
        <news:keywords><![CDATA[alopecia areata,pediatric alopecia areata,JAK inhibitors,boxed warning,step therapy,prior authorization,provider hesitancy]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/gene-therapy-for-wet-amd-near-an-inflection-point-arshad-khanani-md</loc><lastmod>2026-08-10T17:07:19.795Z</lastmod><news:news><news:publication_date>2026-08-10T17:07:19.795Z</news:publication_date>
        <news:title><![CDATA[Gene Therapy for Wet AMD Near an Inflection Point: Arshad Khanani, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/lipoprotein-a-an-faq-on-awareness-risk-and-screening-gaps</loc><lastmod>2026-08-10T15:00:00Z</lastmod><news:news><news:publication_date>2026-08-10T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Lipoprotein(a): An FAQ on Awareness, Risk, and Screening Gaps]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/severe-eczema-more-than-doubles-shingles-risk</loc><lastmod>2026-08-10T13:14:45.768Z</lastmod><news:news><news:publication_date>2026-08-10T13:14:45.768Z</news:publication_date>
        <news:title><![CDATA[Severe Eczema More Than Doubles Shingles Risk]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/potentially-inappropriate-medication-use-following-hospital-discharge-among-medicare-beneficiaries</loc><lastmod>2026-08-10T13:00:00Z</lastmod><news:news><news:publication_date>2026-08-10T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Potentially Inappropriate Medication Use Following Hospital Discharge Among Medicare Beneficiaries]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/reimbursement-and-geography-as-barriers-to-car-t-access</loc><lastmod>2026-08-10T12:05:00Z</lastmod><news:news><news:publication_date>2026-08-10T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Reimbursement and Geography as Barriers to CAR-T Access]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/car-t-therapy-access-unmet-needs-and-geographic-gaps</loc><lastmod>2026-08-10T12:00:00Z</lastmod><news:news><news:publication_date>2026-08-10T12:00:00Z</news:publication_date>
        <news:title><![CDATA[CAR-T Therapy Access: Unmet Needs and Geographic Gaps]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/-20-billion-national-strategy-aims-to-close-the-women-s-health-gap</loc><lastmod>2026-08-09T16:17:00Z</lastmod><news:news><news:publication_date>2026-08-09T16:17:00Z</news:publication_date>
        <news:title><![CDATA[$20 Billion National Strategy Aims to Close the Women's Health Gap]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/earlier-cancer-screening-could-ease-medicaid-costs-anuraag-r-kansal-phd</loc><lastmod>2026-08-09T16:00:00Z</lastmod><news:news><news:publication_date>2026-08-09T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Earlier Cancer Screening Could Ease Medicaid Costs: Anuraag R. Kansal, PhD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/science-fiction-made-real-kerry-rogers-md-on-how-car-t-works</loc><lastmod>2026-08-08T12:00:00Z</lastmod><news:news><news:publication_date>2026-08-08T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Science Fiction Made Real: Kerry Rogers, MD, on How CAR T Works]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/trends-and-disparities-in-high-risk-nonsteroidal-anti-inflammatory-drug-utilization</loc><lastmod>2026-08-07T19:00:00Z</lastmod><news:news><news:publication_date>2026-08-07T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Trends and Disparities in High-Risk Nonsteroidal Anti-Inflammatory Drug Utilization]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/smartwatch-study-links-midlife-to-rising-nighttime-awakenings-in-women</loc><lastmod>2026-08-07T18:55:26.128Z</lastmod><news:news><news:publication_date>2026-08-07T18:55:26.128Z</news:publication_date>
        <news:title><![CDATA[Smartwatch Study Links Midlife to Rising Nighttime Awakenings in Women]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/fda-approves-gwyn-lo-a-new-low-dose-contraceptive-patch</loc><lastmod>2026-08-07T17:56:50.266Z</lastmod><news:news><news:publication_date>2026-08-07T17:56:50.266Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Gwyn Lo, a New Low-Dose Contraceptive Patch]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/global-hepb3-coverage-reaches-81-8-but-regional-gaps-persist</loc><lastmod>2026-08-07T17:55:51.013Z</lastmod><news:news><news:publication_date>2026-08-07T17:55:51.013Z</news:publication_date>
        <news:title><![CDATA[Global HepB3 Coverage Reaches 81.8%, but Regional Gaps Persist]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/rituximab-matches-ocrelizumab-in-head-to-head-ms-trial</loc><lastmod>2026-08-07T17:42:01.526Z</lastmod><news:news><news:publication_date>2026-08-07T17:42:01.526Z</news:publication_date>
        <news:title><![CDATA[Rituximab Matches Ocrelizumab in Head-to-Head MS Trial]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/gaps-persist-in-interstitial-lung-disease-care</loc><lastmod>2026-08-07T17:32:04.278Z</lastmod><news:news><news:publication_date>2026-08-07T17:32:04.278Z</news:publication_date>
        <news:title><![CDATA[Gaps Persist in Interstitial Lung Disease Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/5-novel-fda-approvals-that-signal-a-shift-toward-convenience-driven-care</loc><lastmod>2026-08-07T16:51:52.107Z</lastmod><news:news><news:publication_date>2026-08-07T16:51:52.107Z</news:publication_date>
        <news:title><![CDATA[5 Novel FDA Approvals That Signal a Shift Toward Convenience-Driven Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/social-risk-weighted-scoring-to-improve-medicare-advantage-star-ratings</loc><lastmod>2026-08-07T16:00:00Z</lastmod><news:news><news:publication_date>2026-08-07T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Social Risk–Weighted Scoring to Improve Medicare Advantage Star Ratings]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/ajmc-in-the-press-august-7-2026</loc><lastmod>2026-08-07T13:00:00Z</lastmod><news:news><news:publication_date>2026-08-07T13:00:00Z</news:publication_date>
        <news:title><![CDATA[AJMC® in the Press, August 7, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/prior-authorization-requirements-in-medicare-advantage-and-county-social-vulnerability</loc><lastmod>2026-08-07T13:00:00Z</lastmod><news:news><news:publication_date>2026-08-07T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Prior Authorization Requirements in Medicare Advantage and County Social Vulnerability]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/from-weight-loss-to-liver-normalization-a-deep-dive-into-the-synchronize-1-trial-results</loc><lastmod>2026-08-07T12:05:00Z</lastmod><news:news><news:publication_date>2026-08-07T12:05:00Z</news:publication_date>
        <news:title><![CDATA[From Weight Loss to Liver Normalization: A Deep Dive Into the SYNCHRONIZE-1 Trial Results]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/hr-positive-breast-cancer-ctdna-guided-de-escalation-and-clinical-uncertainty</loc><lastmod>2026-08-07T12:05:00Z</lastmod><news:news><news:publication_date>2026-08-07T12:05:00Z</news:publication_date>
        <news:title><![CDATA[HR-Positive Breast Cancer: ctDNA-Guided De-escalation and Clinical Uncertainty]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/hr-positive-breast-cancer-differentiating-oral-serds-and-real-world-decision-making</loc><lastmod>2026-08-07T12:00:00Z</lastmod><news:news><news:publication_date>2026-08-07T12:00:00Z</news:publication_date>
        <news:title><![CDATA[HR-Positive Breast Cancer: Differentiating Oral SERDs and Real-World Decision-Making]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/glp-1-plus-glucagon-the-mechanistic-case-for-dual-receptor-agonism-in-obesity-and-mash</loc><lastmod>2026-08-07T12:00:00Z</lastmod><news:news><news:publication_date>2026-08-07T12:00:00Z</news:publication_date>
        <news:title><![CDATA[GLP-1 Plus Glucagon: The Mechanistic Case for Dual Receptor Agonism in Obesity and MASH]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/after-wild-ride-fda-grants-accelerated-approval-for-replimune-s-rp1-plus-nivolumab-in-advanced-melanoma</loc><lastmod>2026-08-06T20:30:00Z</lastmod><news:news><news:publication_date>2026-08-06T20:30:00Z</news:publication_date>
        <news:title><![CDATA[After Wild Ride, FDA Grants Accelerated Approval for Replimune’s RP1 Plus Nivolumab in Advanced Melanoma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/high-dose-vitamin-d3-fails-to-improve-pfs-in-phase-3-metastatic-crc-trial</loc><lastmod>2026-08-06T20:03:58.772Z</lastmod><news:news><news:publication_date>2026-08-06T20:03:58.772Z</news:publication_date>
        <news:title><![CDATA[High-Dose Vitamin D3 Fails to Improve PFS in Phase 3 Metastatic CRC Trial]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/almost-no-public-awareness-of-lp-a-elevated-cvd-risk-in-the-us-katherine-wilemon</loc><lastmod>2026-08-06T20:00:00Z</lastmod><news:news><news:publication_date>2026-08-06T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Almost No Public Awareness of Lp(a), Elevated CVD Risk in the US: Katherine Wilemon]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/aha-proposes-staging-system-for-pediatric-cardiogenic-shock</loc><lastmod>2026-08-06T18:47:18.425Z</lastmod><news:news><news:publication_date>2026-08-06T18:47:18.425Z</news:publication_date>
        <news:title><![CDATA[AHA Proposes Staging System for Pediatric Cardiogenic Shock]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/oneoncology-partners-with-openevidence-to-give-physicians-access-within-clinical-workflows</loc><lastmod>2026-08-06T18:18:00Z</lastmod><news:news><news:publication_date>2026-08-06T18:18:00Z</news:publication_date>
        <news:title><![CDATA[OneOncology Partners With OpenEvidence to Give Physicians Access Within Clinical Workflows]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/real-world-polycythemia-care-often-fails-to-control-hematocrit</loc><lastmod>2026-08-06T17:38:52.778Z</lastmod><news:news><news:publication_date>2026-08-06T17:38:52.778Z</news:publication_date>
        <news:title><![CDATA[Real-World Polycythemia Care Often Fails to Control Hematocrit]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/patients-with-masld-had-more-than-2-times-higher-odds-of-eosinophilic-esophagitis-across-age-groups</loc><lastmod>2026-08-06T16:00:00Z</lastmod><news:news><news:publication_date>2026-08-06T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Patients With MASLD Had More Than 2 Times Higher Odds of Eosinophilic Esophagitis Across Age Groups]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/remote-monitoring-and-self-efficacy-implications-for-breast-cancer-survivorship-outcomes</loc><lastmod>2026-08-06T16:00:00Z</lastmod><news:news><news:publication_date>2026-08-06T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Remote Monitoring and Self-Efficacy: Implications for Breast Cancer Survivorship Outcomes]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/considerations-for-the-management-of-overactive-bladder-in-long-term-care</loc><lastmod>2026-08-06T15:50:00Z</lastmod><news:news><news:publication_date>2026-08-06T15:50:00Z</news:publication_date>
        <news:title><![CDATA[Considerations for the Management of Overactive Bladder in Long-Term Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/fda-approves-moderna-s-mrna-flu-vaccine-after-phase-3-success</loc><lastmod>2026-08-06T14:00:17.572Z</lastmod><news:news><news:publication_date>2026-08-06T14:00:17.572Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/full-data-published-showing-87-cr-at-3-years-for-epcoritamab-plus-br-in-first-line-fl</loc><lastmod>2026-08-06T13:16:00Z</lastmod><news:news><news:publication_date>2026-08-06T13:16:00Z</news:publication_date>
        <news:title><![CDATA[Full Data Published Showing 87% CR at 3 Years for Epcoritamab Plus BR in First-Line FL]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/predicting-glp-1-discontinuation-from-pharmacy-claims</loc><lastmod>2026-08-31T16:46:00.000Z</lastmod><news:news><news:publication_date>2026-08-06T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Predicting GLP-1 Discontinuation From Pharmacy Claims]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/translating-pfs-data-for-patients-how-community-oncologists-communicate-trial-outcomes-in-rrfl</loc><lastmod>2026-08-06T12:05:00Z</lastmod><news:news><news:publication_date>2026-08-06T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Translating PFS Data for Patients: How Community Oncologists Communicate Trial Outcomes in RRFL]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/avoiding-tnf-cycling-when-to-switch-drug-classes-in-rheumatoid-arthritis</loc><lastmod>2026-08-06T12:05:00Z</lastmod><news:news><news:publication_date>2026-08-06T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Avoiding TNF Cycling: When to Switch Drug Classes in Rheumatoid Arthritis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/treating-rrfl-in-the-community-how-patient-profiles-and-disease-trajectory-shape-treatment-decisions</loc><lastmod>2026-08-06T12:00:00Z</lastmod><news:news><news:publication_date>2026-08-06T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Treating RRFL in the Community: How Patient Profiles and Disease Trajectory Shape Treatment Decisions]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/setting-treatment-goals-in-ra-remission-joint-damage-and-systemic-risk</loc><lastmod>2026-08-06T12:00:00Z</lastmod><news:news><news:publication_date>2026-08-06T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Setting Treatment Goals in RA: Remission, Joint Damage, and Systemic Risk]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/cann-responds-to-hrsa-s-revised-340b-rebate-model-pilot</loc><lastmod>2026-08-05T21:23:52.352Z</lastmod><news:news><news:publication_date>2026-08-05T21:23:52.352Z</news:publication_date>
        <news:title><![CDATA[CANN Responds to HRSA's Revised 340B Rebate Model Pilot]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/infection-remains-a-major-burden-in-blood-cancers</loc><lastmod>2026-08-05T21:04:14.748Z</lastmod><news:news><news:publication_date>2026-08-05T21:04:14.748Z</news:publication_date>
        <news:title><![CDATA[Infection Remains a Major Burden in Blood Cancers]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/lilly-expands-retatrutide-access-amid-doctor-pushback</loc><lastmod>2026-08-05T20:27:21.598Z</lastmod><news:news><news:publication_date>2026-08-05T20:27:21.598Z</news:publication_date>
        <news:title><![CDATA[Lilly Expands Retatrutide Access Amid Doctor Pushback]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/erica-schwartz-confirmed-as-first-permanent-cdc-director-in-nearly-a-year</loc><lastmod>2026-08-05T19:42:00.360Z</lastmod><news:news><news:publication_date>2026-08-05T19:42:00.360Z</news:publication_date>
        <news:title><![CDATA[Senate Confirms Erica Schwartz as CDC Director After Yearlong Vacancy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/emerging-inhaled-ipf-therapies-show-promise-steven-d-nathan-md</loc><lastmod>2026-08-05T17:13:52.733Z</lastmod><news:news><news:publication_date>2026-08-05T17:13:52.733Z</news:publication_date>
        <news:title><![CDATA[Emerging Inhaled IPF Therapies Show Promise: Steven D. Nathan, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/expanding-donor-access-for-asct-in-aml-karilyn-larkin-md</loc><lastmod>2026-08-05T16:13:43.207Z</lastmod><news:news><news:publication_date>2026-08-05T16:13:43.207Z</news:publication_date>
        <news:title><![CDATA[Expanding Donor Access for ASCT in AML: Karilyn Larkin, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/comparing-cv-safety-and-exploratory-bleeding-outcomes-of-btk-inhibitors-in-mantle-cell-lymphoma</loc><lastmod>2026-08-05T16:11:00Z</lastmod><news:news><news:publication_date>2026-08-05T16:11:00Z</news:publication_date>
        <news:title><![CDATA[Comparing CV Safety and Exploratory Bleeding Outcomes of BTK Inhibitors in Mantle Cell Lymphoma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/atacicept-shows-encouraging-safety-profile-in-iga-nephropathy-richard-lafayette-md</loc><lastmod>2026-08-05T16:00:00Z</lastmod><news:news><news:publication_date>2026-08-05T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Atacicept Shows Encouraging Safety Profile in IgA Nephropathy: Richard Lafayette, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/closing-the-gap-between-myeloma-science-and-access-doris-hansen-md</loc><lastmod>2026-08-05T15:30:00Z</lastmod><news:news><news:publication_date>2026-08-05T15:30:00Z</news:publication_date>
        <news:title><![CDATA[Closing the Gap Between Myeloma Science and Access: Doris Hansen, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/extended-cooling-no-better-than-shorter-duration-after-cardiac-arrest</loc><lastmod>2026-08-05T15:00:00Z</lastmod><news:news><news:publication_date>2026-08-05T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Extended Cooling No Better Than Shorter Duration After Cardiac Arrest]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/small-and-large-left-ventricles-both-linked-to-higher-mortality-in-hf</loc><lastmod>2026-08-05T15:00:00Z</lastmod><news:news><news:publication_date>2026-08-05T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Small and Large Left Ventricles Both Linked to Higher Mortality in HF]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/new-nonprofit-launches-to-develop-peptide-compounding-quality-standards</loc><lastmod>2026-08-05T14:43:03.448Z</lastmod><news:news><news:publication_date>2026-08-05T14:43:03.448Z</news:publication_date>
        <news:title><![CDATA[New Nonprofit Launches to Develop Peptide Compounding Quality Standards]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/recognizing-early-ild-symptoms-can-speed-up-diagnosis-steven-d-nathan-md</loc><lastmod>2026-08-05T13:00:00Z</lastmod><news:news><news:publication_date>2026-08-05T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Recognizing Early ILD Symptoms Can Speed Up Diagnosis: Steven D. Nathan, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/lung-cancer-screening-must-move-beyond-smoking-history</loc><lastmod>2026-08-05T13:00:00Z</lastmod><news:news><news:publication_date>2026-08-05T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Lung Cancer Screening Must Move Beyond Smoking History]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/the-future-of-multiple-myeloma-pipeline-developments-personalized-medicine-and-closing-thoughts</loc><lastmod>2026-08-05T12:00:00Z</lastmod><news:news><news:publication_date>2026-08-05T12:00:00Z</news:publication_date>
        <news:title><![CDATA[The Future of Multiple Myeloma: Pipeline Developments, Personalized Medicine, and Closing Thoughts]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/patient-first-physician-led-the-case-for-independent-community-oncology</loc><lastmod>2026-08-05T10:00:00Z</lastmod><news:news><news:publication_date>2026-08-05T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Patient-First, Physician-Led: The Case for Independent Community Oncology]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/expanding-community-access-to-car-t-bispecific-therapies-in-multiple-myeloma-peter-forsberg-md</loc><lastmod>2026-08-04T20:30:00Z</lastmod><news:news><news:publication_date>2026-08-04T20:30:00Z</news:publication_date>
        <news:title><![CDATA[Expanding Community Access to CAR T, Bispecific Therapies in Multiple Myeloma: Peter Forsberg, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/rising-awareness-of-a-triple-threat-heart-risk-in-the-us-katherine-wilemon</loc><lastmod>2026-08-04T20:23:56.811Z</lastmod><news:news><news:publication_date>2026-08-04T20:23:56.811Z</news:publication_date>
        <news:title><![CDATA[Rising Awareness of a “Triple Threat” Heart Risk in the US: Katherine Wilemon]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/experts-debate-how-to-scale-multidisciplinary-care-for-hfpef-and-hfmref</loc><lastmod>2026-08-04T20:23:19.501Z</lastmod><news:news><news:publication_date>2026-08-04T20:23:19.501Z</news:publication_date>
        <news:title><![CDATA[Experts Debate How to Scale Multidisciplinary Care for HFpEF and HFmrEF]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/microplastics-pose-emerging-health-environmental-risks-with-summer-heat-increasing-exposure</loc><lastmod>2026-08-04T20:15:00Z</lastmod><news:news><news:publication_date>2026-08-04T20:15:00Z</news:publication_date>
        <news:title><![CDATA[Microplastics Pose Emerging Health, Environmental Risks, With Summer Heat Increasing Exposure]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/frameworks-for-advancing-health-equity-community-based-doulas-partner-with-health-plan</loc><lastmod>2026-08-04T20:00:00Z</lastmod><news:news><news:publication_date>2026-08-04T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Frameworks for Advancing Health Equity: Community-Based Doulas Partner with Health Plan]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/multidisciplinary-ild-care-enables-earlier-diagnosis-steven-d-nathan-md</loc><lastmod>2026-08-04T17:09:06.639Z</lastmod><news:news><news:publication_date>2026-08-04T17:09:06.639Z</news:publication_date>
        <news:title><![CDATA[Multidisciplinary ILD Care Enables Earlier Diagnosis: Steven D. Nathan, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/philadelphia-employer-coalition-podcast-targets-glp-1s-cancer-care</loc><lastmod>2026-08-04T13:45:13.968Z</lastmod><news:news><news:publication_date>2026-08-04T13:45:13.968Z</news:publication_date>
        <news:title><![CDATA[Philadelphia Employer Coalition Podcast Targets GLP-1s, Cancer Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/considerations-for-use-of-tebentafusp-a-bite-approved-for-rare-high-risk-uveal-melanoma</loc><lastmod>2026-08-04T13:00:00Z</lastmod><news:news><news:publication_date>2026-08-04T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Considerations for Use of Tebentafusp, a BiTE Approved for Rare, High-Risk Uveal Melanoma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/caregiving-catches-fire-how-a-critical-need-is-showing-up-in-research-legislation-and-the-national-conversation</loc><lastmod>2026-08-04T11:19:00Z</lastmod><news:news><news:publication_date>2026-08-04T11:19:00Z</news:publication_date>
        <news:title><![CDATA[Caregiving Catches Fire: How a Critical Need Is Showing Up in Research, Legislation, and the National Conversation]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/boston-panel-confronts-access-and-coordination-gaps-in-obesity-care</loc><lastmod>2026-08-03T17:39:20.239Z</lastmod><news:news><news:publication_date>2026-08-03T17:39:20.239Z</news:publication_date>
        <news:title><![CDATA[Boston Panel Confronts Access and Coordination Gaps in Obesity Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/fda-approves-lutetium-lu-177-for-earlier-stage-prostate-cancer</loc><lastmod>2026-08-03T17:32:41.524Z</lastmod><news:news><news:publication_date>2026-08-03T17:32:41.524Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Lutetium Lu 177 for Earlier-Stage Prostate Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/expanding-access-to-car-t-bispecific-therapies-requires-system-changes-peter-forsberg-md</loc><lastmod>2026-08-03T17:07:00Z</lastmod><news:news><news:publication_date>2026-08-03T17:07:00Z</news:publication_date>
        <news:title><![CDATA[Expanding Access to CAR T, Bispecific Therapies Requires System Changes: Peter Forsberg, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/atacicept-becomes-first-baff-april-inhibitor-approved-for-iga-nephropathy-richard-lafayette-md</loc><lastmod>2026-08-03T17:00:00Z</lastmod><news:news><news:publication_date>2026-08-03T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Atacicept Becomes First BAFF/APRIL Inhibitor Approved for IgA Nephropathy: Richard Lafayette, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/lgbtq-medical-students-favor-states-with-protections</loc><lastmod>2026-08-03T15:00:00Z</lastmod><news:news><news:publication_date>2026-08-03T15:00:00Z</news:publication_date>
        <news:title><![CDATA[LGBTQ+ Medical Students Favor States With Protections]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/longer-acting-dme-drugs-ease-burden-not-vision-john-kitchens-md</loc><lastmod>2026-08-03T15:00:00Z</lastmod><news:news><news:publication_date>2026-08-03T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Longer-Acting DME Drugs Ease Burden, Not Vision: John Kitchens, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/pediatric-chronic-skin-disorders-linked-to-poorer-mental-health</loc><lastmod>2026-08-03T13:50:05.966Z</lastmod><news:news><news:publication_date>2026-08-03T13:50:05.966Z</news:publication_date>
        <news:title><![CDATA[Pediatric Chronic Skin Disorders Linked to Poorer Mental Health ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/psychiatric-burden-of-pediatric-alopecia-areata-brittany-craiglow-md</loc><lastmod>2026-08-03T13:18:39.631Z</lastmod><news:news><news:publication_date>2026-08-03T13:18:39.631Z</news:publication_date>
        <news:title><![CDATA[The Psychiatric Burden of Pediatric Alopecia Areata: A Q&A With Brittany Craiglow, MD]]></news:title>
        <news:keywords><![CDATA[alopecia areata,pediatric alopecia areata,comorbidities,mental health,anxiety,depression,JAK inhibitors,quality of life]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/from-car-t-cell-therapy-to-adcs-tackling-oncology-access-gaps</loc><lastmod>2026-08-03T12:00:00Z</lastmod><news:news><news:publication_date>2026-08-03T12:00:00Z</news:publication_date>
        <news:title><![CDATA[From CAR T-Cell Therapy to ADCs: Tackling Oncology Access Gaps]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/oncology-leaders-call-for-greater-collaboration-to-advance-precision-medicine-innovative-cancer-care</loc><lastmod>2026-08-02T12:00:00Z</lastmod><news:news><news:publication_date>2026-08-02T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/faqs-cyclospora-recovery-treatment-and-outbreak-prevention-strategies</loc><lastmod>2026-08-01T17:52:00Z</lastmod><news:news><news:publication_date>2026-08-01T17:52:00Z</news:publication_date>
        <news:title><![CDATA[5 FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/teclistamab-talquetamab-combo-cuts-myeloma-progression-risk-by-89-</loc><lastmod>2026-08-01T12:00:00Z</lastmod><news:news><news:publication_date>2026-08-01T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/study-shows-potential-for-low-dose-car-t-with-implications-for-increased-access</loc><lastmod>2026-07-31T19:40:00Z</lastmod><news:news><news:publication_date>2026-07-31T19:40:00Z</news:publication_date>
        <news:title><![CDATA[Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/fda-panel-backs-6-peptides-for-compounding</loc><lastmod>2026-07-31T17:45:34.976Z</lastmod><news:news><news:publication_date>2026-07-31T17:45:34.976Z</news:publication_date>
        <news:title><![CDATA[FDA Panel Backs 6 Peptides for Compounding]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/childhood-hepatitis-b-vaccination-tied-to-lower-coinfection-in-patients-with-hiv</loc><lastmod>2026-07-31T17:00:00Z</lastmod><news:news><news:publication_date>2026-07-31T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Childhood Hepatitis B Vaccination Tied to Lower Coinfection in Patients With HIV]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/health-equity-access-weekly-roundup-july-31-2026</loc><lastmod>2026-07-31T16:00:00Z</lastmod><news:news><news:publication_date>2026-07-31T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Health Equity & Access Weekly Roundup: July 31, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/acalabrutinib-may-weaken-rituximab-s-efficacy-in-cll</loc><lastmod>2026-07-31T16:00:00Z</lastmod><news:news><news:publication_date>2026-07-31T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Acalabrutinib May Weaken Rituximab’s Efficacy in CLL]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/paricalcitol-tied-to-lower-mortality-than-calcitriol-in-ckd</loc><lastmod>2026-07-31T15:00:00Z</lastmod><news:news><news:publication_date>2026-07-31T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Paricalcitol Tied to Lower Mortality Than Calcitriol in CKD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/water-exchange-colonoscopy-raises-adenoma-detection-rate</loc><lastmod>2026-07-31T14:30:00Z</lastmod><news:news><news:publication_date>2026-07-31T14:30:00Z</news:publication_date>
        <news:title><![CDATA[Water Exchange Colonoscopy Raises Adenoma Detection Rate]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/hiv-loss-and-the-power-of-trust-perry-n-halkitis-phd-ms-mph</loc><lastmod>2026-07-31T14:22:13.747Z</lastmod><news:news><news:publication_date>2026-07-31T14:22:13.747Z</news:publication_date>
        <news:title><![CDATA[HIV, Loss, and the Power of Trust: Perry N. Halkitis, PhD, MS, MPH]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/delgocitinib-cream-succeeds-first-phase-3-trial-teens-hand-eczema</loc><lastmod>2026-07-31T13:00:00Z</lastmod><news:news><news:publication_date>2026-07-31T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Delgocitinib Cream Succeeds in Phase 3 Trial for Teens With Hand Eczema]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/ajmc-in-the-press-july-31-2026</loc><lastmod>2026-07-31T13:00:00Z</lastmod><news:news><news:publication_date>2026-07-31T13:00:00Z</news:publication_date>
        <news:title><![CDATA[AJMC® in the Press, July 31, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/bridging-the-gap-between-acr-guidelines-and-real-world-ra-management</loc><lastmod>2026-07-30T12:05:00.000Z</lastmod><news:news><news:publication_date>2026-07-31T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Bridging the Gap Between ACR Guidelines and Real-World RA Management]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url></urlset>